Thymosin alpha-1 blocks the accumulation of myeloid suppressor cells in NSCLC by inhibiting VEGF production-Reference-Cited by-同舟云学术

Thymosin alpha-1 blocks the accumulation of myeloid suppressor cells in NSCLC by inhibiting VEGF production

Published:2020-11 Issue: Volume:131 Page:110740
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Yang Zhenzhen,Guo Jiacheng,Cui Kang,Du Yabing,Zhao Huan,Zhu Lili,Weng Lanling,Tang Wenxue,Guo Jiancheng,Zhang Tengfei,Shi Xiaojing,Zong Hong,Jin Shuiling,Ma Wang^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference42 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Lung cancer statistics;Torre;Adv. Exp. Med. Biol.,2016

3. Myeloid immunosuppression and immune checkpoints in the tumor microenvironment;Nakamura;Cell. Mol. Immunol.,2019

4. The nature of myeloid-derived suppressor cells in the tumor microenvironment;Kumar;Trends Immunol.,2016

5. Increased circulating CD14(+)HLA-DR-/low myeloid-derived suppressor cells are associated with poor prognosis in patients with small-cell lung cancer;Tian;Cancer Biomark.,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma;Molecular Cancer;2023-08-19

2. Thymus-derived hormonal and cellular control of cancer;Frontiers in Endocrinology;2023-07-17

3. Synergistic anti-cancer and attenuation effects of thymosin on chemotherapeutic drug vinorelbine in tumor-bearing zebrafish;Biomedicine & Pharmacotherapy;2023-06

4. Thymosin α-1 in cancer therapy: Immunoregulation and potential applications;International Immunopharmacology;2023-04

5. High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis;Frontiers in Immunology;2022-04-13